Regeneron Pharmaceuticals Inc REGN
$959.41
+4.73%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | PRIMARY DOCUMENT | 2026-11-06 | View → |
| 4 | PRIMARY DOCUMENT | 2026-11-05 | View → |
| 13F-HR | Institutional holdings | 2026-11-05 | View → |
| 4 | PRIMARY DOCUMENT | 2026-11-05 | View → |
| 4 | PRIMARY DOCUMENT | 2026-11-04 | View → |
| 4 | PRIMARY DOCUMENT | 2026-11-04 | View → |
| 4 | PRIMARY DOCUMENT | 2026-11-04 | View → |
| 4 | PRIMARY DOCUMENT | 2026-11-04 | View → |
| 4 | PRIMARY DOCUMENT | 2026-11-03 | View → |
| 4 | PRIMARY DOCUMENT | 2026-11-03 | View → |
| 4 | PRIMARY DOCUMENT | 2026-11-03 | View → |
| 10-Q | 10-Q | 2026-10-30 | View → |
| 8-K | 8-K | 2026-10-30 | View → |
| 4 | PRIMARY DOCUMENT | 2026-10-15 | View → |
| 8-K | FORM 8-K | 2026-10-06 | View → |
| 8-K | FORM 8-K | 2026-09-30 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-03 | View → |
| 4 | PRIMARY DOCUMENT | 2026-09-03 | View → |
| 4 | PRIMARY DOCUMENT | 2026-08-21 | View → |
| 4 | PRIMARY DOCUMENT | 2026-08-20 | View → |
| 4 | PRIMARY DOCUMENT | 2026-08-12 | View → |
| 4 | PRIMARY DOCUMENT | 2026-08-12 | View → |
| 13F-HR | Institutional holdings | 2026-08-07 | View → |
| 10-Q | 10-Q | 2026-07-30 | View → |
| 8-K | 8-K | 2026-07-30 | View → |
| 4 | PRIMARY DOCUMENT | 2026-07-07 | View → |
| 8-K | FORM 8-K | 2026-07-06 | View → |
| 8-K | FORM 8-K | 2026-06-17 | View → |
| 13F-HR | Institutional holdings | 2026-05-08 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-04 | View → |
| 10-Q | 10-Q | 2026-04-29 | View → |
| 8-K | 8-K | 2026-04-29 | View → |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 2026-04-24 | View → |
| 8-K | FORM 8-K | 2026-04-08 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-04-03 | View → |
| 4 | PRIMARY DOCUMENT | 2026-03-03 | View → |
| 4 | PRIMARY DOCUMENT | 2026-02-23 | View → |
| 4 | PRIMARY DOCUMENT | 2026-02-11 | View → |
| 4 | PRIMARY DOCUMENT | 2026-02-11 | View → |
| 13F-HR | Institutional holdings | 2026-02-06 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $959.41
- Market Cap
- $94.76 billion
- 52-Week Range
- $541.00 – $991.73
- Average Volume
- 865K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.